nodes	percent_of_prediction	percent_of_DWPC	metapath
Bisoprolol—CYP3A4—type 2 diabetes mellitus	0.255	1	CbGaD
Bisoprolol—ADRB1—Bromocriptine—type 2 diabetes mellitus	0.0944	0.214	CbGbCtD
Bisoprolol—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.035	0.0795	CbGbCtD
Bisoprolol—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0345	0.0784	CbGbCtD
Bisoprolol—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0323	0.0734	CbGbCtD
Bisoprolol—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0308	0.0699	CbGbCtD
Bisoprolol—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0281	0.0639	CbGbCtD
Bisoprolol—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.0265	0.0602	CbGbCtD
Bisoprolol—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.0254	0.0577	CbGbCtD
Bisoprolol—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0246	0.0559	CbGbCtD
Bisoprolol—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0222	0.0505	CbGbCtD
Bisoprolol—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0169	0.0383	CbGbCtD
Bisoprolol—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0162	0.0367	CbGbCtD
Bisoprolol—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0162	0.0367	CbGbCtD
Bisoprolol—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0153	0.0347	CbGbCtD
Bisoprolol—CYP3A4—Glyburide—type 2 diabetes mellitus	0.0114	0.0259	CbGbCtD
Bisoprolol—CYP3A4—Losartan—type 2 diabetes mellitus	0.0104	0.0237	CbGbCtD
Bisoprolol—Alprenolol—ADRB3—type 2 diabetes mellitus	0.001	0.29	CrCbGaD
Bisoprolol—Pindolol—ADRB3—type 2 diabetes mellitus	0.000861	0.25	CrCbGaD
Bisoprolol—Propranolol—ADRB3—type 2 diabetes mellitus	0.00047	0.136	CrCbGaD
Bisoprolol—Betaxolol—CYP1A2—type 2 diabetes mellitus	0.000379	0.11	CrCbGaD
Bisoprolol—Chlorphenesin—CYP3A4—type 2 diabetes mellitus	0.000249	0.0721	CrCbGaD
Bisoprolol—Chlorphenesin—PTGS2—type 2 diabetes mellitus	0.000244	0.0706	CrCbGaD
Bisoprolol—Propranolol—CYP1A2—type 2 diabetes mellitus	0.000148	0.0428	CrCbGaD
Bisoprolol—Propranolol—CYP3A4—type 2 diabetes mellitus	9.78e-05	0.0284	CrCbGaD
Bisoprolol—Oedema—Metformin—type 2 diabetes mellitus	9.71e-05	0.000405	CcSEcCtD
Bisoprolol—Tinnitus—Ramipril—type 2 diabetes mellitus	9.7e-05	0.000404	CcSEcCtD
Bisoprolol—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	9.67e-05	0.000403	CcSEcCtD
Bisoprolol—Flushing—Ramipril—type 2 diabetes mellitus	9.66e-05	0.000402	CcSEcCtD
Bisoprolol—Angioedema—Losartan—type 2 diabetes mellitus	9.66e-05	0.000402	CcSEcCtD
Bisoprolol—Infection—Metformin—type 2 diabetes mellitus	9.65e-05	0.000402	CcSEcCtD
Bisoprolol—Insomnia—Valsartan—type 2 diabetes mellitus	9.64e-05	0.000402	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	9.6e-05	0.0004	CcSEcCtD
Bisoprolol—Paraesthesia—Valsartan—type 2 diabetes mellitus	9.58e-05	0.000399	CcSEcCtD
Bisoprolol—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	9.56e-05	0.000398	CcSEcCtD
Bisoprolol—Arthralgia—Irbesartan—type 2 diabetes mellitus	9.56e-05	0.000398	CcSEcCtD
Bisoprolol—Chest pain—Irbesartan—type 2 diabetes mellitus	9.56e-05	0.000398	CcSEcCtD
Bisoprolol—Myalgia—Irbesartan—type 2 diabetes mellitus	9.56e-05	0.000398	CcSEcCtD
Bisoprolol—Shock—Metformin—type 2 diabetes mellitus	9.55e-05	0.000398	CcSEcCtD
Bisoprolol—Insomnia—Orlistat—type 2 diabetes mellitus	9.53e-05	0.000397	CcSEcCtD
Bisoprolol—Malaise—Losartan—type 2 diabetes mellitus	9.53e-05	0.000397	CcSEcCtD
Bisoprolol—Anxiety—Irbesartan—type 2 diabetes mellitus	9.53e-05	0.000397	CcSEcCtD
Bisoprolol—Hypersensitivity—Glyburide—type 2 diabetes mellitus	9.52e-05	0.000397	CcSEcCtD
Bisoprolol—Nervous system disorder—Metformin—type 2 diabetes mellitus	9.52e-05	0.000397	CcSEcCtD
Bisoprolol—Thrombocytopenia—Metformin—type 2 diabetes mellitus	9.51e-05	0.000396	CcSEcCtD
Bisoprolol—Dyspnoea—Valsartan—type 2 diabetes mellitus	9.51e-05	0.000396	CcSEcCtD
Bisoprolol—Vertigo—Losartan—type 2 diabetes mellitus	9.49e-05	0.000396	CcSEcCtD
Bisoprolol—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	9.49e-05	0.000396	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	9.49e-05	0.000395	CcSEcCtD
Bisoprolol—Somnolence—Valsartan—type 2 diabetes mellitus	9.48e-05	0.000395	CcSEcCtD
Bisoprolol—Syncope—Losartan—type 2 diabetes mellitus	9.48e-05	0.000395	CcSEcCtD
Bisoprolol—Paraesthesia—Orlistat—type 2 diabetes mellitus	9.46e-05	0.000394	CcSEcCtD
Bisoprolol—Discomfort—Irbesartan—type 2 diabetes mellitus	9.44e-05	0.000393	CcSEcCtD
Bisoprolol—Skin disorder—Metformin—type 2 diabetes mellitus	9.43e-05	0.000393	CcSEcCtD
Bisoprolol—Hyperhidrosis—Metformin—type 2 diabetes mellitus	9.39e-05	0.000391	CcSEcCtD
Bisoprolol—Dyspepsia—Valsartan—type 2 diabetes mellitus	9.39e-05	0.000391	CcSEcCtD
Bisoprolol—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	9.38e-05	0.000391	CcSEcCtD
Bisoprolol—Dizziness—Bromocriptine—type 2 diabetes mellitus	9.35e-05	0.00039	CcSEcCtD
Bisoprolol—Dry mouth—Irbesartan—type 2 diabetes mellitus	9.35e-05	0.000389	CcSEcCtD
Bisoprolol—Palpitations—Losartan—type 2 diabetes mellitus	9.34e-05	0.000389	CcSEcCtD
Bisoprolol—Nausea—Glimepiride—type 2 diabetes mellitus	9.31e-05	0.000388	CcSEcCtD
Bisoprolol—Arrhythmia—Ramipril—type 2 diabetes mellitus	9.3e-05	0.000387	CcSEcCtD
Bisoprolol—Loss of consciousness—Losartan—type 2 diabetes mellitus	9.29e-05	0.000387	CcSEcCtD
Bisoprolol—Nausea—Sitagliptin—type 2 diabetes mellitus	9.28e-05	0.000387	CcSEcCtD
Bisoprolol—Dyspepsia—Orlistat—type 2 diabetes mellitus	9.28e-05	0.000386	CcSEcCtD
Bisoprolol—Asthenia—Glyburide—type 2 diabetes mellitus	9.27e-05	0.000386	CcSEcCtD
Bisoprolol—Cough—Losartan—type 2 diabetes mellitus	9.22e-05	0.000384	CcSEcCtD
Bisoprolol—Urticaria—Gliclazide—type 2 diabetes mellitus	9.22e-05	0.000384	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	9.21e-05	0.000384	CcSEcCtD
Bisoprolol—Alopecia—Ramipril—type 2 diabetes mellitus	9.2e-05	0.000383	CcSEcCtD
Bisoprolol—Fatigue—Valsartan—type 2 diabetes mellitus	9.19e-05	0.000383	CcSEcCtD
Bisoprolol—Abdominal pain—Gliclazide—type 2 diabetes mellitus	9.18e-05	0.000382	CcSEcCtD
Bisoprolol—Body temperature increased—Gliclazide—type 2 diabetes mellitus	9.18e-05	0.000382	CcSEcCtD
Bisoprolol—Oedema—Irbesartan—type 2 diabetes mellitus	9.16e-05	0.000382	CcSEcCtD
Bisoprolol—Pruritus—Glyburide—type 2 diabetes mellitus	9.14e-05	0.000381	CcSEcCtD
Bisoprolol—Mental disorder—Ramipril—type 2 diabetes mellitus	9.12e-05	0.00038	CcSEcCtD
Bisoprolol—Constipation—Valsartan—type 2 diabetes mellitus	9.12e-05	0.00038	CcSEcCtD
Bisoprolol—Infection—Irbesartan—type 2 diabetes mellitus	9.1e-05	0.000379	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	9.1e-05	0.000379	CcSEcCtD
Bisoprolol—Fatigue—Orlistat—type 2 diabetes mellitus	9.08e-05	0.000378	CcSEcCtD
Bisoprolol—Hypotension—Metformin—type 2 diabetes mellitus	9.07e-05	0.000378	CcSEcCtD
Bisoprolol—Erythema—Ramipril—type 2 diabetes mellitus	9.06e-05	0.000377	CcSEcCtD
Bisoprolol—Shock—Irbesartan—type 2 diabetes mellitus	9.02e-05	0.000376	CcSEcCtD
Bisoprolol—Pain—Orlistat—type 2 diabetes mellitus	9.01e-05	0.000375	CcSEcCtD
Bisoprolol—Arthralgia—Losartan—type 2 diabetes mellitus	9e-05	0.000375	CcSEcCtD
Bisoprolol—Chest pain—Losartan—type 2 diabetes mellitus	9e-05	0.000375	CcSEcCtD
Bisoprolol—Myalgia—Losartan—type 2 diabetes mellitus	9e-05	0.000375	CcSEcCtD
Bisoprolol—Vomiting—Bromocriptine—type 2 diabetes mellitus	8.99e-05	0.000375	CcSEcCtD
Bisoprolol—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	8.99e-05	0.000374	CcSEcCtD
Bisoprolol—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	8.97e-05	0.000374	CcSEcCtD
Bisoprolol—Anxiety—Losartan—type 2 diabetes mellitus	8.97e-05	0.000373	CcSEcCtD
Bisoprolol—Tachycardia—Irbesartan—type 2 diabetes mellitus	8.94e-05	0.000373	CcSEcCtD
Bisoprolol—Rash—Bromocriptine—type 2 diabetes mellitus	8.92e-05	0.000371	CcSEcCtD
Bisoprolol—Dermatitis—Bromocriptine—type 2 diabetes mellitus	8.91e-05	0.000371	CcSEcCtD
Bisoprolol—Skin disorder—Irbesartan—type 2 diabetes mellitus	8.9e-05	0.000371	CcSEcCtD
Bisoprolol—Discomfort—Losartan—type 2 diabetes mellitus	8.89e-05	0.00037	CcSEcCtD
Bisoprolol—Dysgeusia—Ramipril—type 2 diabetes mellitus	8.87e-05	0.00037	CcSEcCtD
Bisoprolol—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	8.86e-05	0.000369	CcSEcCtD
Bisoprolol—Headache—Bromocriptine—type 2 diabetes mellitus	8.86e-05	0.000369	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	8.85e-05	0.000369	CcSEcCtD
Bisoprolol—Diarrhoea—Glyburide—type 2 diabetes mellitus	8.84e-05	0.000368	CcSEcCtD
Bisoprolol—Dry mouth—Losartan—type 2 diabetes mellitus	8.8e-05	0.000367	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	8.72e-05	0.000363	CcSEcCtD
Bisoprolol—Paraesthesia—Metformin—type 2 diabetes mellitus	8.72e-05	0.000363	CcSEcCtD
Bisoprolol—Muscle spasms—Ramipril—type 2 diabetes mellitus	8.71e-05	0.000363	CcSEcCtD
Bisoprolol—Confusional state—Losartan—type 2 diabetes mellitus	8.7e-05	0.000362	CcSEcCtD
Bisoprolol—Feeling abnormal—Orlistat—type 2 diabetes mellitus	8.68e-05	0.000362	CcSEcCtD
Bisoprolol—Dyspnoea—Metformin—type 2 diabetes mellitus	8.66e-05	0.000361	CcSEcCtD
Bisoprolol—Somnolence—Metformin—type 2 diabetes mellitus	8.63e-05	0.00036	CcSEcCtD
Bisoprolol—Oedema—Losartan—type 2 diabetes mellitus	8.62e-05	0.000359	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	8.62e-05	0.000359	CcSEcCtD
Bisoprolol—Infection—Losartan—type 2 diabetes mellitus	8.57e-05	0.000357	CcSEcCtD
Bisoprolol—Hypotension—Irbesartan—type 2 diabetes mellitus	8.56e-05	0.000357	CcSEcCtD
Bisoprolol—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	8.55e-05	0.000356	CcSEcCtD
Bisoprolol—Dyspepsia—Metformin—type 2 diabetes mellitus	8.55e-05	0.000356	CcSEcCtD
Bisoprolol—Tremor—Ramipril—type 2 diabetes mellitus	8.49e-05	0.000354	CcSEcCtD
Bisoprolol—Shock—Losartan—type 2 diabetes mellitus	8.48e-05	0.000353	CcSEcCtD
Bisoprolol—Urticaria—Valsartan—type 2 diabetes mellitus	8.47e-05	0.000353	CcSEcCtD
Bisoprolol—Nervous system disorder—Losartan—type 2 diabetes mellitus	8.46e-05	0.000352	CcSEcCtD
Bisoprolol—Thrombocytopenia—Losartan—type 2 diabetes mellitus	8.44e-05	0.000352	CcSEcCtD
Bisoprolol—Abdominal pain—Valsartan—type 2 diabetes mellitus	8.43e-05	0.000351	CcSEcCtD
Bisoprolol—Tachycardia—Losartan—type 2 diabetes mellitus	8.42e-05	0.000351	CcSEcCtD
Bisoprolol—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	8.41e-05	0.00035	CcSEcCtD
Bisoprolol—Nausea—Bromocriptine—type 2 diabetes mellitus	8.4e-05	0.00035	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	8.38e-05	0.000349	CcSEcCtD
Bisoprolol—Fatigue—Metformin—type 2 diabetes mellitus	8.37e-05	0.000349	CcSEcCtD
Bisoprolol—Urticaria—Orlistat—type 2 diabetes mellitus	8.37e-05	0.000349	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	8.35e-05	0.000348	CcSEcCtD
Bisoprolol—Hyperhidrosis—Losartan—type 2 diabetes mellitus	8.34e-05	0.000347	CcSEcCtD
Bisoprolol—Abdominal pain—Orlistat—type 2 diabetes mellitus	8.33e-05	0.000347	CcSEcCtD
Bisoprolol—Body temperature increased—Orlistat—type 2 diabetes mellitus	8.33e-05	0.000347	CcSEcCtD
Bisoprolol—Asthenia—Gliclazide—type 2 diabetes mellitus	8.33e-05	0.000347	CcSEcCtD
Bisoprolol—Agitation—Ramipril—type 2 diabetes mellitus	8.33e-05	0.000347	CcSEcCtD
Bisoprolol—Constipation—Metformin—type 2 diabetes mellitus	8.3e-05	0.000346	CcSEcCtD
Bisoprolol—Angioedema—Ramipril—type 2 diabetes mellitus	8.28e-05	0.000345	CcSEcCtD
Bisoprolol—Paraesthesia—Irbesartan—type 2 diabetes mellitus	8.23e-05	0.000343	CcSEcCtD
Bisoprolol—Vomiting—Glyburide—type 2 diabetes mellitus	8.22e-05	0.000342	CcSEcCtD
Bisoprolol—Pruritus—Gliclazide—type 2 diabetes mellitus	8.21e-05	0.000342	CcSEcCtD
Bisoprolol—Malaise—Ramipril—type 2 diabetes mellitus	8.17e-05	0.00034	CcSEcCtD
Bisoprolol—Dyspnoea—Irbesartan—type 2 diabetes mellitus	8.17e-05	0.00034	CcSEcCtD
Bisoprolol—Rash—Glyburide—type 2 diabetes mellitus	8.15e-05	0.00034	CcSEcCtD
Bisoprolol—Somnolence—Irbesartan—type 2 diabetes mellitus	8.15e-05	0.000339	CcSEcCtD
Bisoprolol—Dermatitis—Glyburide—type 2 diabetes mellitus	8.14e-05	0.000339	CcSEcCtD
Bisoprolol—Vertigo—Ramipril—type 2 diabetes mellitus	8.14e-05	0.000339	CcSEcCtD
Bisoprolol—Syncope—Ramipril—type 2 diabetes mellitus	8.13e-05	0.000339	CcSEcCtD
Bisoprolol—Headache—Glyburide—type 2 diabetes mellitus	8.1e-05	0.000337	CcSEcCtD
Bisoprolol—Dyspepsia—Irbesartan—type 2 diabetes mellitus	8.07e-05	0.000336	CcSEcCtD
Bisoprolol—Hypotension—Losartan—type 2 diabetes mellitus	8.06e-05	0.000336	CcSEcCtD
Bisoprolol—Palpitations—Ramipril—type 2 diabetes mellitus	8.01e-05	0.000334	CcSEcCtD
Bisoprolol—Feeling abnormal—Metformin—type 2 diabetes mellitus	8e-05	0.000333	CcSEcCtD
Bisoprolol—Loss of consciousness—Ramipril—type 2 diabetes mellitus	7.96e-05	0.000332	CcSEcCtD
Bisoprolol—Diarrhoea—Gliclazide—type 2 diabetes mellitus	7.94e-05	0.000331	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	7.94e-05	0.000331	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	7.91e-05	0.00033	CcSEcCtD
Bisoprolol—Cough—Ramipril—type 2 diabetes mellitus	7.91e-05	0.000329	CcSEcCtD
Bisoprolol—Fatigue—Irbesartan—type 2 diabetes mellitus	7.9e-05	0.000329	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	7.86e-05	0.000327	CcSEcCtD
Bisoprolol—Hypersensitivity—Valsartan—type 2 diabetes mellitus	7.86e-05	0.000327	CcSEcCtD
Bisoprolol—Pain—Irbesartan—type 2 diabetes mellitus	7.84e-05	0.000326	CcSEcCtD
Bisoprolol—Constipation—Irbesartan—type 2 diabetes mellitus	7.84e-05	0.000326	CcSEcCtD
Bisoprolol—Insomnia—Losartan—type 2 diabetes mellitus	7.8e-05	0.000325	CcSEcCtD
Bisoprolol—Hypersensitivity—Orlistat—type 2 diabetes mellitus	7.76e-05	0.000323	CcSEcCtD
Bisoprolol—Paraesthesia—Losartan—type 2 diabetes mellitus	7.74e-05	0.000323	CcSEcCtD
Bisoprolol—Urticaria—Metformin—type 2 diabetes mellitus	7.71e-05	0.000321	CcSEcCtD
Bisoprolol—Myalgia—Ramipril—type 2 diabetes mellitus	7.71e-05	0.000321	CcSEcCtD
Bisoprolol—Arthralgia—Ramipril—type 2 diabetes mellitus	7.71e-05	0.000321	CcSEcCtD
Bisoprolol—Chest pain—Ramipril—type 2 diabetes mellitus	7.71e-05	0.000321	CcSEcCtD
Bisoprolol—Dyspnoea—Losartan—type 2 diabetes mellitus	7.69e-05	0.00032	CcSEcCtD
Bisoprolol—Anxiety—Ramipril—type 2 diabetes mellitus	7.69e-05	0.00032	CcSEcCtD
Bisoprolol—Nausea—Glyburide—type 2 diabetes mellitus	7.68e-05	0.00032	CcSEcCtD
Bisoprolol—Abdominal pain—Metformin—type 2 diabetes mellitus	7.68e-05	0.00032	CcSEcCtD
Bisoprolol—Dizziness—Gliclazide—type 2 diabetes mellitus	7.68e-05	0.00032	CcSEcCtD
Bisoprolol—Somnolence—Losartan—type 2 diabetes mellitus	7.67e-05	0.000319	CcSEcCtD
Bisoprolol—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	7.66e-05	0.000319	CcSEcCtD
Bisoprolol—Asthenia—Valsartan—type 2 diabetes mellitus	7.65e-05	0.000319	CcSEcCtD
Bisoprolol—Discomfort—Ramipril—type 2 diabetes mellitus	7.62e-05	0.000318	CcSEcCtD
Bisoprolol—Dyspepsia—Losartan—type 2 diabetes mellitus	7.59e-05	0.000316	CcSEcCtD
Bisoprolol—Asthenia—Orlistat—type 2 diabetes mellitus	7.56e-05	0.000315	CcSEcCtD
Bisoprolol—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	7.55e-05	0.000315	CcSEcCtD
Bisoprolol—Pruritus—Valsartan—type 2 diabetes mellitus	7.54e-05	0.000314	CcSEcCtD
Bisoprolol—Dry mouth—Ramipril—type 2 diabetes mellitus	7.54e-05	0.000314	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	7.49e-05	0.000312	CcSEcCtD
Bisoprolol—Confusional state—Ramipril—type 2 diabetes mellitus	7.46e-05	0.000311	CcSEcCtD
Bisoprolol—Pruritus—Orlistat—type 2 diabetes mellitus	7.45e-05	0.000311	CcSEcCtD
Bisoprolol—Fatigue—Losartan—type 2 diabetes mellitus	7.44e-05	0.00031	CcSEcCtD
Bisoprolol—Oedema—Ramipril—type 2 diabetes mellitus	7.39e-05	0.000308	CcSEcCtD
Bisoprolol—Vomiting—Gliclazide—type 2 diabetes mellitus	7.38e-05	0.000307	CcSEcCtD
Bisoprolol—Pain—Losartan—type 2 diabetes mellitus	7.37e-05	0.000307	CcSEcCtD
Bisoprolol—Constipation—Losartan—type 2 diabetes mellitus	7.37e-05	0.000307	CcSEcCtD
Bisoprolol—Rash—Gliclazide—type 2 diabetes mellitus	7.32e-05	0.000305	CcSEcCtD
Bisoprolol—Dermatitis—Gliclazide—type 2 diabetes mellitus	7.31e-05	0.000305	CcSEcCtD
Bisoprolol—Diarrhoea—Valsartan—type 2 diabetes mellitus	7.3e-05	0.000304	CcSEcCtD
Bisoprolol—Urticaria—Irbesartan—type 2 diabetes mellitus	7.28e-05	0.000303	CcSEcCtD
Bisoprolol—Shock—Ramipril—type 2 diabetes mellitus	7.28e-05	0.000303	CcSEcCtD
Bisoprolol—Headache—Gliclazide—type 2 diabetes mellitus	7.27e-05	0.000303	CcSEcCtD
Bisoprolol—Nervous system disorder—Ramipril—type 2 diabetes mellitus	7.25e-05	0.000302	CcSEcCtD
Bisoprolol—Abdominal pain—Irbesartan—type 2 diabetes mellitus	7.24e-05	0.000302	CcSEcCtD
Bisoprolol—Body temperature increased—Irbesartan—type 2 diabetes mellitus	7.24e-05	0.000302	CcSEcCtD
Bisoprolol—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	7.24e-05	0.000302	CcSEcCtD
Bisoprolol—Tachycardia—Ramipril—type 2 diabetes mellitus	7.22e-05	0.000301	CcSEcCtD
Bisoprolol—Diarrhoea—Orlistat—type 2 diabetes mellitus	7.21e-05	0.0003	CcSEcCtD
Bisoprolol—Skin disorder—Ramipril—type 2 diabetes mellitus	7.18e-05	0.000299	CcSEcCtD
Bisoprolol—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	7.15e-05	0.000298	CcSEcCtD
Bisoprolol—Feeling abnormal—Losartan—type 2 diabetes mellitus	7.11e-05	0.000296	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	7.05e-05	0.000294	CcSEcCtD
Bisoprolol—Dizziness—Valsartan—type 2 diabetes mellitus	7.05e-05	0.000294	CcSEcCtD
Bisoprolol—Dizziness—Orlistat—type 2 diabetes mellitus	6.97e-05	0.00029	CcSEcCtD
Bisoprolol—Asthenia—Metformin—type 2 diabetes mellitus	6.97e-05	0.00029	CcSEcCtD
Bisoprolol—Hypotension—Ramipril—type 2 diabetes mellitus	6.91e-05	0.000288	CcSEcCtD
Bisoprolol—Nausea—Gliclazide—type 2 diabetes mellitus	6.89e-05	0.000287	CcSEcCtD
Bisoprolol—Pruritus—Metformin—type 2 diabetes mellitus	6.87e-05	0.000286	CcSEcCtD
Bisoprolol—Urticaria—Losartan—type 2 diabetes mellitus	6.85e-05	0.000285	CcSEcCtD
Bisoprolol—Body temperature increased—Losartan—type 2 diabetes mellitus	6.82e-05	0.000284	CcSEcCtD
Bisoprolol—Abdominal pain—Losartan—type 2 diabetes mellitus	6.82e-05	0.000284	CcSEcCtD
Bisoprolol—Vomiting—Valsartan—type 2 diabetes mellitus	6.78e-05	0.000282	CcSEcCtD
Bisoprolol—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	6.75e-05	0.000281	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	6.74e-05	0.000281	CcSEcCtD
Bisoprolol—Rash—Valsartan—type 2 diabetes mellitus	6.72e-05	0.00028	CcSEcCtD
Bisoprolol—Dermatitis—Valsartan—type 2 diabetes mellitus	6.72e-05	0.00028	CcSEcCtD
Bisoprolol—Vomiting—Orlistat—type 2 diabetes mellitus	6.7e-05	0.000279	CcSEcCtD
Bisoprolol—Insomnia—Ramipril—type 2 diabetes mellitus	6.69e-05	0.000279	CcSEcCtD
Bisoprolol—Headache—Valsartan—type 2 diabetes mellitus	6.68e-05	0.000278	CcSEcCtD
Bisoprolol—Diarrhoea—Metformin—type 2 diabetes mellitus	6.64e-05	0.000277	CcSEcCtD
Bisoprolol—Rash—Orlistat—type 2 diabetes mellitus	6.64e-05	0.000277	CcSEcCtD
Bisoprolol—Paraesthesia—Ramipril—type 2 diabetes mellitus	6.64e-05	0.000277	CcSEcCtD
Bisoprolol—Dermatitis—Orlistat—type 2 diabetes mellitus	6.64e-05	0.000277	CcSEcCtD
Bisoprolol—Headache—Orlistat—type 2 diabetes mellitus	6.6e-05	0.000275	CcSEcCtD
Bisoprolol—Dyspnoea—Ramipril—type 2 diabetes mellitus	6.59e-05	0.000275	CcSEcCtD
Bisoprolol—Asthenia—Irbesartan—type 2 diabetes mellitus	6.57e-05	0.000274	CcSEcCtD
Bisoprolol—Somnolence—Ramipril—type 2 diabetes mellitus	6.57e-05	0.000274	CcSEcCtD
Bisoprolol—Dyspepsia—Ramipril—type 2 diabetes mellitus	6.51e-05	0.000271	CcSEcCtD
Bisoprolol—Pruritus—Irbesartan—type 2 diabetes mellitus	6.48e-05	0.00027	CcSEcCtD
Bisoprolol—Dizziness—Metformin—type 2 diabetes mellitus	6.42e-05	0.000268	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	6.38e-05	0.000266	CcSEcCtD
Bisoprolol—Fatigue—Ramipril—type 2 diabetes mellitus	6.38e-05	0.000266	CcSEcCtD
Bisoprolol—Hypersensitivity—Losartan—type 2 diabetes mellitus	6.35e-05	0.000265	CcSEcCtD
Bisoprolol—Nausea—Valsartan—type 2 diabetes mellitus	6.33e-05	0.000264	CcSEcCtD
Bisoprolol—Constipation—Ramipril—type 2 diabetes mellitus	6.32e-05	0.000263	CcSEcCtD
Bisoprolol—Diarrhoea—Irbesartan—type 2 diabetes mellitus	6.27e-05	0.000261	CcSEcCtD
Bisoprolol—Nausea—Orlistat—type 2 diabetes mellitus	6.26e-05	0.000261	CcSEcCtD
Bisoprolol—Asthenia—Losartan—type 2 diabetes mellitus	6.19e-05	0.000258	CcSEcCtD
Bisoprolol—Vomiting—Metformin—type 2 diabetes mellitus	6.17e-05	0.000257	CcSEcCtD
Bisoprolol—Rash—Metformin—type 2 diabetes mellitus	6.12e-05	0.000255	CcSEcCtD
Bisoprolol—Dermatitis—Metformin—type 2 diabetes mellitus	6.12e-05	0.000255	CcSEcCtD
Bisoprolol—Pruritus—Losartan—type 2 diabetes mellitus	6.1e-05	0.000254	CcSEcCtD
Bisoprolol—Feeling abnormal—Ramipril—type 2 diabetes mellitus	6.09e-05	0.000254	CcSEcCtD
Bisoprolol—Headache—Metformin—type 2 diabetes mellitus	6.08e-05	0.000253	CcSEcCtD
Bisoprolol—Dizziness—Irbesartan—type 2 diabetes mellitus	6.06e-05	0.000252	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	6.05e-05	0.000252	CcSEcCtD
Bisoprolol—Diarrhoea—Losartan—type 2 diabetes mellitus	5.9e-05	0.000246	CcSEcCtD
Bisoprolol—Urticaria—Ramipril—type 2 diabetes mellitus	5.87e-05	0.000245	CcSEcCtD
Bisoprolol—Body temperature increased—Ramipril—type 2 diabetes mellitus	5.85e-05	0.000244	CcSEcCtD
Bisoprolol—Abdominal pain—Ramipril—type 2 diabetes mellitus	5.85e-05	0.000244	CcSEcCtD
Bisoprolol—Vomiting—Irbesartan—type 2 diabetes mellitus	5.83e-05	0.000243	CcSEcCtD
Bisoprolol—Rash—Irbesartan—type 2 diabetes mellitus	5.78e-05	0.000241	CcSEcCtD
Bisoprolol—Dermatitis—Irbesartan—type 2 diabetes mellitus	5.77e-05	0.00024	CcSEcCtD
Bisoprolol—Nausea—Metformin—type 2 diabetes mellitus	5.77e-05	0.00024	CcSEcCtD
Bisoprolol—Headache—Irbesartan—type 2 diabetes mellitus	5.74e-05	0.000239	CcSEcCtD
Bisoprolol—Dizziness—Losartan—type 2 diabetes mellitus	5.7e-05	0.000238	CcSEcCtD
Bisoprolol—Vomiting—Losartan—type 2 diabetes mellitus	5.48e-05	0.000228	CcSEcCtD
Bisoprolol—Hypersensitivity—Ramipril—type 2 diabetes mellitus	5.45e-05	0.000227	CcSEcCtD
Bisoprolol—Nausea—Irbesartan—type 2 diabetes mellitus	5.44e-05	0.000227	CcSEcCtD
Bisoprolol—Rash—Losartan—type 2 diabetes mellitus	5.44e-05	0.000227	CcSEcCtD
Bisoprolol—Dermatitis—Losartan—type 2 diabetes mellitus	5.43e-05	0.000226	CcSEcCtD
Bisoprolol—Headache—Losartan—type 2 diabetes mellitus	5.4e-05	0.000225	CcSEcCtD
Bisoprolol—Asthenia—Ramipril—type 2 diabetes mellitus	5.31e-05	0.000221	CcSEcCtD
Bisoprolol—Pruritus—Ramipril—type 2 diabetes mellitus	5.23e-05	0.000218	CcSEcCtD
Bisoprolol—Nausea—Losartan—type 2 diabetes mellitus	5.12e-05	0.000213	CcSEcCtD
Bisoprolol—Diarrhoea—Ramipril—type 2 diabetes mellitus	5.06e-05	0.000211	CcSEcCtD
Bisoprolol—Dizziness—Ramipril—type 2 diabetes mellitus	4.89e-05	0.000204	CcSEcCtD
Bisoprolol—Vomiting—Ramipril—type 2 diabetes mellitus	4.7e-05	0.000196	CcSEcCtD
Bisoprolol—Rash—Ramipril—type 2 diabetes mellitus	4.66e-05	0.000194	CcSEcCtD
Bisoprolol—Dermatitis—Ramipril—type 2 diabetes mellitus	4.66e-05	0.000194	CcSEcCtD
Bisoprolol—Headache—Ramipril—type 2 diabetes mellitus	4.63e-05	0.000193	CcSEcCtD
Bisoprolol—Nausea—Ramipril—type 2 diabetes mellitus	4.39e-05	0.000183	CcSEcCtD
Bisoprolol—ADRB2—Signaling Pathways—EDNRA—type 2 diabetes mellitus	1.57e-05	0.000255	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—GHRL—type 2 diabetes mellitus	1.56e-05	0.000255	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—PLAT—type 2 diabetes mellitus	1.56e-05	0.000255	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—CALM1—type 2 diabetes mellitus	1.56e-05	0.000254	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—CYBA—type 2 diabetes mellitus	1.56e-05	0.000254	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—CALCA—type 2 diabetes mellitus	1.54e-05	0.000251	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	1.54e-05	0.000251	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	1.53e-05	0.00025	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—GHRL—type 2 diabetes mellitus	1.53e-05	0.000249	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—PLAT—type 2 diabetes mellitus	1.53e-05	0.000249	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—CALCA—type 2 diabetes mellitus	1.51e-05	0.000246	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	1.5e-05	0.000244	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—PCK1—type 2 diabetes mellitus	1.5e-05	0.000244	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	1.47e-05	0.000239	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	1.45e-05	0.000237	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	1.45e-05	0.000236	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—GCG—type 2 diabetes mellitus	1.43e-05	0.000233	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	1.43e-05	0.000233	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	1.42e-05	0.000232	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	1.42e-05	0.000232	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	1.42e-05	0.000232	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	1.42e-05	0.000231	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	1.41e-05	0.000229	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—HK1—type 2 diabetes mellitus	1.4e-05	0.000229	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	1.4e-05	0.000228	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—GCG—type 2 diabetes mellitus	1.4e-05	0.000228	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—PTPN1—type 2 diabetes mellitus	1.4e-05	0.000228	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	1.38e-05	0.000224	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	1.37e-05	0.000224	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	1.37e-05	0.000224	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	1.37e-05	0.000224	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	1.37e-05	0.000224	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.37e-05	0.000224	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	1.37e-05	0.000223	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—HSD3B2—type 2 diabetes mellitus	1.36e-05	0.000221	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—KCNJ11—type 2 diabetes mellitus	1.36e-05	0.000221	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—GCKR—type 2 diabetes mellitus	1.36e-05	0.000221	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—LPA—type 2 diabetes mellitus	1.36e-05	0.000221	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	1.34e-05	0.000218	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	1.33e-05	0.000217	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	1.31e-05	0.000214	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	1.31e-05	0.000214	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—CCL2—type 2 diabetes mellitus	1.31e-05	0.000213	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—ALDOB—type 2 diabetes mellitus	1.3e-05	0.000212	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—AKT2—type 2 diabetes mellitus	1.29e-05	0.000209	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	1.28e-05	0.000209	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	1.26e-05	0.000205	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	1.26e-05	0.000205	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	1.24e-05	0.000203	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.23e-05	0.000201	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	1.23e-05	0.0002	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	1.22e-05	0.000198	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—AVP—type 2 diabetes mellitus	1.22e-05	0.000198	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.22e-05	0.000198	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.21e-05	0.000197	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—GLP1R—type 2 diabetes mellitus	1.21e-05	0.000197	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.2e-05	0.000196	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.2e-05	0.000196	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	1.19e-05	0.000194	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—AVP—type 2 diabetes mellitus	1.19e-05	0.000194	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.19e-05	0.000194	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.18e-05	0.000193	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.18e-05	0.000192	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—APOB—type 2 diabetes mellitus	1.17e-05	0.000191	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.17e-05	0.000191	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	1.17e-05	0.00019	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	1.17e-05	0.00019	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	1.17e-05	0.00019	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	1.17e-05	0.00019	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.16e-05	0.000188	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—APOB—type 2 diabetes mellitus	1.15e-05	0.000187	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.14e-05	0.000186	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.13e-05	0.000184	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—SLC2A2—type 2 diabetes mellitus	1.13e-05	0.000184	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—LPL—type 2 diabetes mellitus	1.12e-05	0.000183	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	1.12e-05	0.000183	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	1.12e-05	0.000183	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—MTR—type 2 diabetes mellitus	1.1e-05	0.00018	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—CPT1A—type 2 diabetes mellitus	1.1e-05	0.00018	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.1e-05	0.000179	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—LPL—type 2 diabetes mellitus	1.1e-05	0.000179	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—NAMPT—type 2 diabetes mellitus	1.08e-05	0.000176	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	1.08e-05	0.000176	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	1.08e-05	0.000176	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—HBA1—type 2 diabetes mellitus	1.08e-05	0.000175	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—GCK—type 2 diabetes mellitus	1.08e-05	0.000175	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—LIPC—type 2 diabetes mellitus	1.08e-05	0.000175	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.07e-05	0.000175	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—CYP11A1—type 2 diabetes mellitus	1.07e-05	0.000174	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	1.06e-05	0.000173	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.05e-05	0.000171	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—SLC9A1—type 2 diabetes mellitus	1.05e-05	0.000171	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	1.04e-05	0.00017	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	1.04e-05	0.00017	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	1.04e-05	0.00017	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—CETP—type 2 diabetes mellitus	1.04e-05	0.000169	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.03e-05	0.000168	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.03e-05	0.000168	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.01e-05	0.000165	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—C3—type 2 diabetes mellitus	1.01e-05	0.000164	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—C3—type 2 diabetes mellitus	9.88e-06	0.000161	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	9.8e-06	0.00016	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	9.66e-06	0.000157	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	9.66e-06	0.000157	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	9.66e-06	0.000157	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	9.63e-06	0.000157	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—IRS2—type 2 diabetes mellitus	9.6e-06	0.000156	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—AGT—type 2 diabetes mellitus	9.59e-06	0.000156	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	9.48e-06	0.000154	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—CALM1—type 2 diabetes mellitus	9.43e-06	0.000154	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	9.42e-06	0.000153	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—LEP—type 2 diabetes mellitus	9.4e-06	0.000153	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—APOE—type 2 diabetes mellitus	9.4e-06	0.000153	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—IRS2—type 2 diabetes mellitus	9.4e-06	0.000153	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	9.39e-06	0.000153	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—AGT—type 2 diabetes mellitus	9.38e-06	0.000153	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—APOA1—type 2 diabetes mellitus	9.29e-06	0.000151	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—CALM1—type 2 diabetes mellitus	9.23e-06	0.00015	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—APOE—type 2 diabetes mellitus	9.19e-06	0.00015	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—LEP—type 2 diabetes mellitus	9.19e-06	0.00015	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	9.19e-06	0.00015	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	9.17e-06	0.000149	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—APOA1—type 2 diabetes mellitus	9.09e-06	0.000148	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	8.86e-06	0.000144	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	8.86e-06	0.000144	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	8.86e-06	0.000144	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	8.86e-06	0.000144	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	8.86e-06	0.000144	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	8.83e-06	0.000144	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	8.73e-06	0.000142	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	8.73e-06	0.000142	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	8.67e-06	0.000141	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	8.52e-06	0.000139	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	8.49e-06	0.000138	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—IRS1—type 2 diabetes mellitus	8.38e-06	0.000137	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	8.37e-06	0.000136	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	8.37e-06	0.000136	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—IRS1—type 2 diabetes mellitus	8.2e-06	0.000134	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—INS—type 2 diabetes mellitus	8.03e-06	0.000131	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—CCL2—type 2 diabetes mellitus	7.9e-06	0.000129	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	7.9e-06	0.000129	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—INS—type 2 diabetes mellitus	7.85e-06	0.000128	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—IGF1—type 2 diabetes mellitus	7.77e-06	0.000127	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—AKT2—type 2 diabetes mellitus	7.76e-06	0.000126	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	7.73e-06	0.000126	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—CCL2—type 2 diabetes mellitus	7.73e-06	0.000126	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—IGF1—type 2 diabetes mellitus	7.6e-06	0.000124	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—AKT2—type 2 diabetes mellitus	7.59e-06	0.000124	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	7.56e-06	0.000123	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	7.38e-06	0.00012	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	7.37e-06	0.00012	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	7.22e-06	0.000118	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	7.22e-06	0.000118	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	7.22e-06	0.000118	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	7.22e-06	0.000118	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	7.21e-06	0.000118	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	7.18e-06	0.000117	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	7.09e-06	0.000115	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	7.08e-06	0.000115	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	7.04e-06	0.000115	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—NOS3—type 2 diabetes mellitus	7.04e-06	0.000115	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	7.04e-06	0.000115	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	7.04e-06	0.000115	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	7.04e-06	0.000115	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	6.99e-06	0.000114	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	6.89e-06	0.000112	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—NOS3—type 2 diabetes mellitus	6.89e-06	0.000112	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	6.88e-06	0.000112	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	6.87e-06	0.000112	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	6.79e-06	0.000111	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	6.69e-06	0.000109	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—RELA—type 2 diabetes mellitus	6.63e-06	0.000108	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	6.57e-06	0.000107	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—RELA—type 2 diabetes mellitus	6.48e-06	0.000106	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	6.43e-06	0.000105	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	6.41e-06	0.000104	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	6.31e-06	0.000103	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	6.31e-06	0.000103	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	6.31e-06	0.000103	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	6.24e-06	0.000102	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	6.2e-06	0.000101	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	6.16e-06	0.0001	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	6.14e-06	0.0001	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	6.03e-06	9.83e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	6.01e-06	9.79e-05	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.98e-06	9.74e-05	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—IL6—type 2 diabetes mellitus	5.94e-06	9.68e-05	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	5.91e-06	9.64e-05	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	5.9e-06	9.62e-05	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.85e-06	9.53e-05	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—IL6—type 2 diabetes mellitus	5.81e-06	9.46e-05	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	5.8e-06	9.45e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	5.77e-06	9.41e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	5.71e-06	9.3e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	5.71e-06	9.3e-05	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.65e-06	9.2e-05	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	5.62e-06	9.16e-05	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.59e-06	9.11e-05	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.53e-06	9e-05	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	5.53e-06	9e-05	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	5.51e-06	8.97e-05	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	5.48e-06	8.93e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	5.47e-06	8.92e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	5.47e-06	8.92e-05	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.47e-06	8.91e-05	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	5.44e-06	8.87e-05	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	5.36e-06	8.73e-05	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—SRC—type 2 diabetes mellitus	5.21e-06	8.48e-05	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—SRC—type 2 diabetes mellitus	5.1e-06	8.3e-05	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	5.07e-06	8.26e-05	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.96e-06	8.08e-05	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	4.8e-06	7.81e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	4.72e-06	7.68e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.72e-06	7.68e-05	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	4.7e-06	7.66e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	4.7e-06	7.65e-05	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.66e-06	7.58e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	4.63e-06	7.55e-05	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.57e-06	7.44e-05	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.55e-06	7.42e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	4.5e-06	7.33e-05	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.47e-06	7.27e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	4.38e-06	7.13e-05	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	4.31e-06	7.03e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	4.3e-06	7e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	4.2e-06	6.85e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	4.19e-06	6.83e-05	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	4.13e-06	6.72e-05	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	4.13e-06	6.72e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	4.08e-06	6.65e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	4.03e-06	6.56e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	3.87e-06	6.3e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	3.79e-06	6.18e-05	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	3.77e-06	6.15e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	3.67e-06	5.99e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	3.61e-06	5.89e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	3.6e-06	5.86e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	3.56e-06	5.8e-05	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—IL6—type 2 diabetes mellitus	3.51e-06	5.72e-05	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—IL6—type 2 diabetes mellitus	3.43e-06	5.59e-05	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.24e-06	5.27e-05	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.17e-06	5.16e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	3.14e-06	5.11e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	3.08e-06	5.01e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	2.82e-06	4.59e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	2.7e-06	4.39e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	2.7e-06	4.39e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	2.47e-06	4.02e-05	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	1.9e-06	3.09e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	1.24e-06	2.02e-05	CbGpPWpGaD
